Q32 Bio Inc. (QTTB) is a Biotechnology company in the Healthcare sector, currently trading at $6.09. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of QTTB = $67.82 (+1013.6% from the current price, the stock appears undervalued). Analyst consensus target is QTTB = $13 (+113.5% upside).
Valuation: QTTB trades at a trailing Price-to-Earnings (P/E) of 2.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.03.
Financials: revenue is $54M, -200%/yr average growth. Net income is $30M, growing at +49.4%/yr. Net profit margin is 55.5% (strong). Gross margin is 99.3% (+38.4 pp trend).
Balance sheet: total debt is $15M against $42M equity (Debt-to-Equity (D/E) ratio 0.37, conservative). Current ratio is 4.85 (strong liquidity). Debt-to-assets is 24.8%. Total assets: $62M.
Analyst outlook: 2 / 7 analysts rate QTTB as buy (29%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future 52/100 (Partial), Income 100/100 (Pass).
